While the stock market stubbornly continues to rise, more American consumers feel as though they’re struggling. Axios senior ...

Stocks traded mixed on Friday even as major indexes tallied another strong week. Investors were eyeing a meeting between ...

Is this time different? "It better be," warns BofA strategist Michael Hartnett. By one metric, stock valuations are beyond ...

Citi raised its forecast for where the S&P 500 will finish the year, joining Bank of America, Goldman Sachs, Deutsche Bank ...

There's record amounts of cash on the sidelines in money market funds, but putting cash to work as the market swoons can be ...

What’s especially troubling is the way the multiple reached its current heights. The main driver wasn’t what matters most: ...

“For the Europeans who are responsible for the future, this is a material wake-up call,” said Stéphane Boujnah, chief ...

Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's ...

In the face of a frothy market, financial expert Jim Cramer encourages investors to stay the course, highlighting numerous ...

Weak growth forecasts and housing market challenges impact Toro's outlook. Near-term growth is muted. See here for more on ...

A Renaissance in IPO Mania The IPO market in 2025 has been a hotbed of opportunity, particularly for crypto-related companies ...

Viking Therapeutics' dual-formulation obesity program could capture the most profitable patient segment starting in 2027. At 29 times forward earnings, Lilly stock assumes flawless execution with no ...